Using an NMR metabolomics approach, COVID-19 patients were characterized by alterations in several lipoproteins (decreased total and HDL apolipoprotein A1, low HDL triglycerides, and increased LDL and VLDL triglycerides) using quantitative measurements of lipoprotein subfractions [17]. Here, APOA1 is linked to COVID-19.